Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,658 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ; British Hypertension Society's PATHWAY Studies Group. Williams B, et al. Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20. Lancet. 2015. PMID: 26414968 Free PMC article. Clinical Trial.
Pharmacological management of hypertension.
Higgins B, Williams B; Guideline Development Group. Higgins B, et al. Among authors: williams b. Clin Med (Lond). 2007 Dec;7(6):612-6. doi: 10.7861/clinmedicine.7-6-612. Clin Med (Lond). 2007. PMID: 18193713 Free PMC article. Review.
Systolic pressure is all that matters.
Williams B, Lindholm LH, Sever P. Williams B, et al. Lancet. 2008 Jun 28;371(9631):2219-21. doi: 10.1016/S0140-6736(08)60804-1. Epub 2008 Jun 16. Lancet. 2008. PMID: 18561995 Review. No abstract available.
Resistant hypertension: an unmet treatment need.
Williams B. Williams B. Lancet. 2009 Oct 24;374(9699):1396-8. doi: 10.1016/S0140-6736(09)61600-7. Epub 2009 Sep 11. Lancet. 2009. PMID: 19748666 No abstract available.
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism.
Parthasarathy HK, Ménard J, White WB, Young WF Jr, Williams GH, Williams B, Ruilope LM, McInnes GT, Connell JM, MacDonald TM. Parthasarathy HK, et al. Among authors: williams gh, williams b. J Hypertens. 2011 May;29(5):980-90. doi: 10.1097/HJH.0b013e3283455ca5. J Hypertens. 2011. PMID: 21451421 Clinical Trial.
6,658 results